|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||0.00 - 0.00|
|Beta (5Y monthly)||1.00|
|PE ratio (TTM)||0.31|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Cosmo Pharmaceuticals ( VTX:COPN ) First Half 2023 Results Key Financial Results Revenue: €43.7m (up 5.2% from 1H...
Key Insights The considerable ownership by private companies in Cosmo Pharmaceuticals indicates that they collectively...
Readers hoping to buy Cosmo Pharmaceuticals N.V. ( VTX:COPN ) for its dividend will need to make their move shortly, as...